Above all pharma companies are a business

  • Pharma companies don’t really care about patients despite all their hubris.
  • PhRMA has already spent $21 million on lobbying this year — a sum that puts it on course to smash its previous annual lobbying records.
  • Pharmaceutical companies have been top performers in the healthcare sector in an era of aging populations, rising health care costs, and the ongoing development of new and extremely profitable medicines.
  • Research shows that 78 percent of patents approved by the U.S. Food and Drug Administration correspond to medications already on the market.
  • Large pharma companies spend more on share buybacks to boost share prices (and stock options — the main way that executives get paid) than on research and development.

Continue reading